Risk of second malignancies among survivors of pediatric thyroid cancer.
Marwan H AdlyMohamed SobhyMohamed A RezkMedhat IshakMahmoud A AfifiAyman El ShafieMahmoud Ahmed AliWael ZekriAhmad Samir AlfaarWafaa M RashedPublished in: International journal of clinical oncology (2018)
Race, gender, histological subtypes, and radioactive iodine are potentially significant prognostic factors for the development of SM among pediatric thyroid cancer survivors. Identification of underlying mechanisms that raise the risk of SM is important for both treatment and follow-up strategies.